Trial · NCT01778556
Adverse events45
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 45
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | decreased appetite | Metabolism and nutrition disorders | Intervention 1 (5 Days) : Leptin Naive | 0 | 15 | 0 |
| other | decreased appetite | Metabolism and nutrition disorders | Intervention 2 (14 Days): Leptin Naive | 0 | 15 | 0 |
| other | decreased appetite | Metabolism and nutrition disorders | Long-term Follow-up (6 Months): Leptin Naive | 1 | 15 | 1 |
| other | decreased appetite | Metabolism and nutrition disorders | Intervention 1 ( 5 Days) : On-Leptin | 8 | ||
| other | decreased appetite | Metabolism and nutrition disorders | Intervention 1 ( 14 Days): On-Leptin | 8 | ||
| other | weight loss | Metabolism and nutrition disorders | Intervention 1 (5 Days) : Leptin Naive | 0 | 15 | 0 |
| other | weight loss | Metabolism and nutrition disorders | Intervention 2 (14 Days): Leptin Naive | 0 | 15 | 0 |
| other | weight loss | Metabolism and nutrition disorders | Long-term Follow-up (6 Months): Leptin Naive | 1 | 15 | 1 |
| other | weight loss | Metabolism and nutrition disorders | Intervention 1 ( 5 Days) : On-Leptin | 8 | ||
| other | weight loss | Metabolism and nutrition disorders | Intervention 1 ( 14 Days): On-Leptin | 8 | ||
| other | hair loss | Skin and subcutaneous tissue disorders | Intervention 1 (5 Days) : Leptin Naive | 0 | 15 | 0 |
| other | hair loss | Skin and subcutaneous tissue disorders | Intervention 2 (14 Days): Leptin Naive | 0 | 15 | 0 |
| other | hair loss | Skin and subcutaneous tissue disorders | Long-term Follow-up (6 Months): Leptin Naive | 1 | 15 | 1 |
| other | hair loss | Skin and subcutaneous tissue disorders | Intervention 1 ( 5 Days) : On-Leptin | 8 | ||
| other | hair loss | Skin and subcutaneous tissue disorders | Intervention 1 ( 14 Days): On-Leptin | 8 | ||
| other | hypoglycemia (in a subject treated with insulin) | Metabolism and nutrition disorders | Intervention 1 (5 Days) : Leptin Naive | 0 | 15 | 0 |
| other | hypoglycemia (in a subject treated with insulin) | Metabolism and nutrition disorders | Intervention 2 (14 Days): Leptin Naive | 0 | 15 | 0 |
| other | hypoglycemia (in a subject treated with insulin) | Metabolism and nutrition disorders | Long-term Follow-up (6 Months): Leptin Naive | 1 | 15 | 1 |
| other | hypoglycemia (in a subject treated with insulin) | Metabolism and nutrition disorders | Intervention 1 ( 5 Days) : On-Leptin | 8 | ||
| other | hypoglycemia (in a subject treated with insulin) | Metabolism and nutrition disorders | Intervention 1 ( 14 Days): On-Leptin | 8 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01778556/events